Long-term Follow-up in the Sudden Cardiac Death Heart Failure Trial (SCD-HEFT)
Gust H. Bardy(University of Washington), Jill Anderson(University of Washington), Kevin Anstrom(PragmatIC (United Kingdom)), Daniel B. Mark(Duke University), Linda Davidson‐Ray(National Institutes of Health), Jeanne E. Poole(Heart Rhythm Society), Kerry Lee(National Institute of Education), Robin Boineau(National Heart Lung and Blood Institute), George Johnson(George Washington University), Daniel Fishbein(National Institutes of Health), Anne S. Hellkamp(Clinical Research Institute)
Cited by 7
Related Papers
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
|Circulation|2014|1k
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke
|Circulation|2003|753
Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation
|JAMA|2019|598
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain
|Circulation|2017|450
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure
|Journal of Cardiac Failure|2022|406